{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:05:33Z","timestamp":1759017933385,"version":"3.44.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.annder.2010.01.013","type":"journal-article","created":{"date-parts":[[2010,2,21]],"date-time":"2010-02-21T04:28:54Z","timestamp":1266726534000},"page":"230-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["M\u00e9lanome sur site d\u2019ex\u00e9r\u00e8se d\u2019un n\u00e6vus dysplasique au cours d\u2019un traitement par \u00e9tanercept"],"prefix":"10.1016","volume":"137","author":[{"given":"F.","family":"Hacard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Bens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Maitre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Le Bidre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Est\u00e8ve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2010.01.013_bib1","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1136\/ard.2004.033993","article-title":"Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumor necrosis factor antagonists","volume":"64","author":"Askling","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.annder.2010.01.013_bib2","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.annder.2010.01.013_bib3","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group","volume":"343","author":"Lipsky","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2010.01.013_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0151-9638(07)89187-3","article-title":"Manifestations cutan\u00e9es observ\u00e9es au cours d\u2019un traitement par anti-TNF alpha\u00a0: 11\u00a0observations","volume":"134","author":"Lebas","year":"2007","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2010.01.013_bib5","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2165\/0002018-200831120-00009","article-title":"Serious events with infliximab in patients with inflammatory bowel disease: a 9-year cohort study in the Netherlands","volume":"31","author":"De Vries","year":"2008","journal-title":"Drug Safety"},{"key":"10.1016\/j.annder.2010.01.013_bib6","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jaad.2006.12.024","article-title":"Eruptive latent metastatic melanomas after initiation of antitumor necrosis factor therapies","volume":"56","author":"Fulchiero","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2010.01.013_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00005-007-0031-9","article-title":"Anti-tumor action of tumor necrosis factor against Borminski Ab melanoma in hamsters","volume":"55","author":"Kosza\u0142ka","year":"2007","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.annder.2010.01.013_bib8","first-page":"2130","article-title":"Skin cancer, rheumatoid arthritis and tumor necrosis factor inhibitors","volume":"32","author":"Chakravarty","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.annder.2010.01.013_bib9","first-page":"454","article-title":"R\u00e9currences tardives de m\u00e9lanome au-del\u00e0 de 10\u00a0ans","volume":"121","author":"Avril","year":"1994","journal-title":"Ann Dermatol Venereol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963810000220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963810000220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:56:37Z","timestamp":1758970597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963810000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0151963810000220"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2010.01.013","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"M\u00e9lanome sur site d\u2019ex\u00e9r\u00e8se d\u2019un n\u00e6vus dysplasique au cours d\u2019un traitement par \u00e9tanercept","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2010.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}